BMJ 1997;314:737 (8 March)

Education and debate

Guidelines for drug donations

H V Hogerzeil, medical officer,a M R Couper, medical officer,b R Gray, consultant c

a Action programme on essential drugs, World health organisation, 1211 Geneva, Switzerland, b Division of drug management and policies, WHO, c Division of emergency and humanitarian action, WHO

Correspondence to: Dr Hogerzell


right arrow   Abstract
up arrowTop
dotAbstract
down arrowThe need for guidelines
down arrowDeveloping guidelines for drug...
down arrowOther ways donors can...
down arrowHow to implement a...
down arrowReferences

Drug donations are usually given in response to acute emergencies, but they can also be part of development aid. Donations may be given directly by governments, by non-governmental organisations, as corporate donations (direct or through private voluntary organisations), or as private donations to single health facilities. Although there are legitimate differences between these donations, basic rules should apply to them all. This common core of "good donation practice" is the basis for new guidelines which have recently been issued by the World Health Organisation after consultation with all relevant United Nations agencies, the Red Cross, and other major international agencies active in humanitarian emergency relief. This article summarises the need for such guidelines, the development process, the core principles, and the guidelines themselves and gives practical advice to recipients and donor agencies.


right arrow   The need for guidelines
up arrowTop
up arrowAbstract
dotThe need for guidelines
down arrowDeveloping guidelines for drug...
down arrowOther ways donors can...
down arrowHow to implement a...
down arrowReferences

International humanitarian relief efforts in natural or other disasters can greatly benefit from donations of appropriate drugs. Unfortunately, there are also many examples of drug donations which cause problems instead of being helpful. For example, after the 1988 earthquake in Armenia, 5000 tons of drugs and medical supplies worth $55m (£36m) were sent, which took 50 people six months to sort out. Only 30% of the drugs were easy to identify and only 42% were relevant for an emergency situation. Most were labelled with only brand names.1 Eritrea received seven truck loads of expired aspirin tablets that took six months to burn; a container full of unsolicited cardiovascular drugs with two months to expiry; and 30 000 bottles of expired amino acid infusion that could not be disposed of anywhere near a settlement because of the smell.2 War torn southern Sudan received donations of contact lens solution, appetite stimulants, drugs against hypercholesterolaemia, and expired antibiotics, all labelled in French.3 In 1992 11 women in Lithuania temporarily lost their eyesight after taking a donated drug. The drug, closantel, was a veterinary anthelmintic but was mistakenly given to treat endometriosis. It had been received without product information and doctors had tried to identify the product by matching its name with those on leaflets of other products.4 Of all drugs received by the World Health Organisation field office in Zagreb in 1994, 15% were completely unusable and 30% were not needed.5 By the end of 1995, 340 tons of expired drugs were stored in Mostar. Most of these were donated by European nations, and the mayor has written to the European Union requesting international help to have them destroyed.



View larger version (76K):
[in this window]
[in a new window]
 
Fig 1 Voluntary worker trying to sort out donated medicines in Mexico, 1991.

WHO/PAHO

The main problems that occur with donations are as follows:

  • Donated drugs are often not relevant for the emergency situation, for the disease pattern, or for the level of care available. They are often unknown by local health professionals and patients and may not comply with locally agreed drug policies and standard treatment guidelines; they may even be dangerous, as the case in Lithuania illustrates

  • Many donated drugs arrive unsorted and labelled in a language which is not easily understood. Some donated drugs come under trade names which are not registered for use in the recipient country and without an international non-proprietary name (generic name) on the label (fig 1)

  • The quality of the drugs does not always comply with standards in the donor country. For example, donated drugs may have expired before they reach the patient, or they may be drugs or samples returned to pharmacies by patients or doctors

  • The donor agency sometimes ignores local administrative procedures for receiving and distributing medical supplies. The distribution plan of the donor agencies may conflict with the policies and wishes of national authorities

  • Donated drugs may have a high declared value–for example, the market value in the donor country rather than the world market price for the generic equivalent. Import taxes and overheads for storage are usually charged as a percentage of the declared value and may then become unnecessarily high. In some recipient countries the ministry of finance considers a donation removes their obligation to fund the necessary drug budget of the ministry of health, which is then reduced accordingly

  • Drugs may be donated in the wrong quantities and some stocks may have to be destroyed. This is wasteful and creates problems of disposal at the receiving end; moreover, stockpiling unused drugs encourages pilfering and black market sales.

There are several underlying reasons for these problems. Probably the most important factor is the common but mistaken belief that in an acute emergency, or for developing countries, any drug is better than none at all. Another important factor is a general lack of communication between donors and recipients, leading to many unnecessary donations. This is unfortunate because in disaster situations and war zones inappropriate drug donations create an extra workload in sorting, storage, and distribution and can easily overstretch the human and transport resources. Often the total handling costs (duties, storage, transport) are higher than the value of the drugs.


right arrow   Developing guidelines for drug donations
up arrowTop
up arrowAbstract
up arrowThe need for guidelines
dotDeveloping guidelines for drug...
down arrowOther ways donors can...
down arrowHow to implement a...
down arrowReferences

In the early 1980s the first guidelines for drug donations were developed by international humanitarian organisations such as the Christian Medical Commission of the World Council of Churches.6 In 1990 the WHO Action Programme on Essential Drugs, in close collaboration with the major international emergency aid agencies, issued a first set of WHO guidelines for donors,7 later refined by the WHO expert committee on the use of essential drugs.8 In 1994 the WHO office in Zagreb issued specific guidelines for humanitarian assistance to former Yugoslavia.9

It soon became clear that one comprehensive set of core principles and guidelines was needed that would be endorsed and used by all major international agencies active in emergency relief. For this reason WHO started a global consultative process to reach consensus with the United Nations High Commissioner for Refugees and Unicef, the Red Cross, and other non-governmental organisations (see acknowledgements). Comments from over 100 humanitarian aid organisations and experts were taken into consideration. The guidelines were issued in May 1996 and have been well received. Many countries have adopted them wholesale and others have adapted them to their specific situation. The guidelines will be reviewed after one year, but it seems that they are already having a significant impact on donation practice.



View larger version (87K):
[in this window]
[in a new window]
 
Fig 2 Distribution of standardised kits of essential drugs in former Yugoslavia. All boxes are labelled with a packing list on the outside. Green is the international colour code for emergency medicines

B OBERSON/ICRC

Box box gives the four core principles. The first is that a drug donation should benefit the recipient to the maximum extent possible. This implies that all donations should be based on an expressed need and that unsolicited drug donations are to be discouraged. The second principle is that a donation should be given with full respect for the wishes and authority of the recipient, and support existing government health policies and administrative arrangements. The third is that there should be no double standards in quality: if the quality of an item is unacceptable in the donor country it is also unacceptable as a donation. The fourth principle is that there should be effective communication between the donor and the recipient; donations should never be sent unannounced.


Box 1–Core principles for drug

  • Maximum benefit to the recipient

  • Respect for the wishes and authority of the recipient

  • No double standards in drug quality

  • Effective communication between donor and recipient

Box box summarises the guidelines for drug donations; the full text and explanatory notes are available elsewhere.10


Box 2–Guidelines for drug donations

Selection of drugs

  • All drug donations should be based on an expressed need and be relevant to the disease pattern in the recipient country. Drugs should not be sent without prior consent from the recipient

  • All donated drugs or their generic equivalents should be approved for use in the recipient country and appear on the national list of essential drugs, or, if a national list is not available, on the WHO model list of essential drugs, unless the recipient specifically requests otherwise

  • The presentation, strength, and formulation of donated drugs should, as much as possible, be similar to those commonly used in the recipient country

Quality assurance and shelf life

  • All donated drugs should be obtained from a reliable source and comply with quality standards in both donor and recipient countries. The WHO certification scheme on the quality of pharmaceutical products moving in international commerce should be used

  • No drugs should be donated that have been issued to patients and then returned to a pharmacy or elsewhere or been given to health professionals as free samples

  • After arrival in the recipient country all donated drugs should have a remaining shelf life of at least one year

Presentation, packing, and labelling

  • All drugs should be labelled in a language that is easily understood by health professionals in the recipient country; the label on each container should include at least the international non-proprietary (generic) name, batch number, dosage form, strength, name of manufacturer, quantity, storage conditions, and expiry date

  • As much as possible donated drugs should be presented in larger quantity units and hospital packs

  • All drug donations should be packed in accordance with international shipping regulations and be accompanied by a detailed packing list which specifies the contents of each numbered carton by generic name, dosage form, quantity, batch number, expiry date, volume, weight, and any special storage conditions. The weight per carton should not exceed 50 kg. Drugs should not be mixed with other supplies in the same carton

Information and management

  • Recipients should be informed of all drug donations that are being considered, prepared, or delivered

  • In the recipient country the declared value of a drug should be based on the wholesale price of its generic equivalent in the recipient country, or, if such information is not available, on the wholesale world market price for its generic equivalent

  • Costs of international and local transport, warehousing, port clearance, and appropriate storage and handling should be paid by the donor unless agreed otherwise with the recipient in advance


right arrow   Other ways donors can help
up arrowTop
up arrowAbstract
up arrowThe need for guidelines
up arrowDeveloping guidelines for drug...
dotOther ways donors can...
down arrowHow to implement a...
down arrowReferences

New emergency health kit
Immediately after an emergency, or when refugees have no medical care, it is better to send standardised kits of drugs and medical supplies that are specifically designed for this purpose (fig 2). For example, the new emergency health kit,7 11 which has been widely used since 1990, contains drugs, disposable supplies, and basic equipment needed for general medical care for a population of 10 000 for three months. It is permanently stocked by several major international suppliers and can be available within 48 hours. It is especially relevant in the absence of specific requests.

Donations in cash
After the initial phase of the emergency is over a cash donation to buy drugs locally or regionally is usually much more welcome than further drug donations.

Drug donations as part of development aid
When drug donations are given as humanitarian support to long lasting complex emergencies or as regular development aid there is more time to consider the recipient's specific demands. Drugs should not arrive in an administrative vacuum; drug donations should not create an abnormal situation which may obstruct or delay the building of national capacity to select, procure, distribute, and rationally use drugs. Special care should be taken to ensure that the donated drugs respond to an expressed need, comply with the national drug policy, and meet national treatment guidelines. Administratively, the drugs should be treated as if they were bought. This means that they should be authorised for use in the country through the same registration and quality assurance procedures that are used for government tenders. If cost sharing procedures are operational, donated drugs should not automatically be distributed free of charge.


right arrow   How to implement a policy on drug donations
up arrowTop
up arrowAbstract
up arrowThe need for guidelines
up arrowDeveloping guidelines for drug...
up arrowOther ways donors can...
dotHow to implement a...
down arrowReferences

Actions required from recipients
It is difficult for a recipient to refuse a donation that has already arrived; prevention is therefore better than cure. Recipients should indicate to prospective donors what kind of help they need and how they would like to receive it. To this end recipients should first formulate their own national guidelines for drug donations, on the basis of the WHO guidelines, and present them to their donors.

Recipients should also develop administrative procedures to maximise the potential benefit of drug donations. The following important questions have to be addressed in advance:

  • Who coordinates all drug donations?

  • Which documents are needed when a donation is planned; who should receive them?

  • What are the criteria for accepting/rejecting a donation; who makes the final decision?

  • Which procedure is used when donations do not follow the guidelines?

  • Who coordinates reception, storage, and distribution of the donated drugs?

  • How are donations valued and entered into the budget/expenditure records?

  • How will inappropriate donations be disposed of?

The third important action by the recipient is to specify its needs as much as possible, indicating the required quantities and prioritising the items. Information on other donations that are already in the pipeline is helpful to potential donors. Full openness by the recipient is greatly appreciated by donors and pays off in the long run.

Finally, the value of donated drugs can be considerable, and the gift should be treated with due care. On arrival the drugs should be inspected and their receipt confirmed to the donor agency. They should then be stored and distributed in accordance with normal principles of good pharmacy practice. There must be vigilance to ensure that donated products are not diverted for export, for commercial sale, or into illicit channels.

Action required from donor agencies
Donors should always respect the four core principles for drug donations. Donors should also respect any national guidelines for drug donations and respond to the priority needs indicated by the recipient. Unsolicited donations should be prevented as much as possible. Ask for full information from the recipient about requested and approved donations. Donors should also inform the recipient well in advance and in great detail about which donations are coming, and when. This will help the recipient country to plan for the proper reception of the donations, to inform other donors, and to identify any additional needs.


right arrow   Acknowledgements

The guidelines for drug donations were issued by the WHO Action Programme on Essential Drugs as an interagency statement by WHO, Unicef, the Office of the United Nations High Commissioner for Refugees, the International Committee of the Red Cross, the International Federation of Red Cross and Red Crescent Societies, Churches' Action for Health of the World Council of Churches, Médecins sans Frontières, and Oxfam. The valuable comments and contributions by all other organisations and individuals are gratefully acknowledged.


right arrow   References
up arrowTop
up arrowAbstract
up arrowThe need for guidelines
up arrowDeveloping guidelines for drug...
up arrowOther ways donors can...
up arrowHow to implement a...
dotReferences

  1. Autier P, Férir M-C, Hairapetien A, Alexanian A, Agoudjian V, Schmets G, et al. Drug supply in the aftermath of the 1988 Armenian earthquake. Lancet 1990;335:1388-90.
  2. Woldeyesus K, Snell B. Eritrea's policy on donations. Lancet 1994;344:879. [Medline]
  3. Cohen S. Drug donations to Sudan. Lancet 1990;335:745.
  4. Hoen E, Hodgkin C. Harmful use of donated veterinary drug. Lancet 1993;342:308-9.
  5. Forte GB. An ounce of prevention is worth a pound of cure. The Hague: International Conference of Drug Regulatory Agencies, 1994.
  6. Christian Medical Commission. Guidelines for donors and recipients of pharmaceutical donations. Geneva: World Council of Churches, 1990.
  7. World Health Organisation. The new emergency health kit. Geneva: WHO, 1990:5. (WHO/DAP/90.1.)
  8. World Health Organisation. The use of essential drugs. World Health Organ Tech Rep Ser 1992;825:13.
  9. World Health Organisation. Medical supplies donor guidelines for WHO humanitarian assistance for former Yugoslavia. Zagreb: WHO, 1994.
  10. World Health Organisation. Guidelines for drug donations. Geneva: WHO, 1996. (WHO/DAP/96.2.)
  11. Hogerzeil HV. Emergency health kits. Lancet 1990;336:1194.
(Accepted 22 November 1996)


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Donations of orthopaedic equipment also cause problems
Alberto Gregori
BMJ 1997 314: 1906. [Extract] [Full Text]

This article has been cited by other articles:

  • Quaglio, G. L., Mezzelani, P., Cuchillo, C. (1999). Drugs arriving in Kosovo need checking. BMJ 319: 1007-1007 [Full text]  
  • Aplenc, R., Kent, D., Glatzer, M., Hoehn, J. B., Forte, G.-B., Alderslade, R., Autier, P., Berckmans, P., Schmets, G. (1998). Inappropriate Drug-Donation Practices in Bosnia and Herzegovina. NEJM 338: 1472-1474 [Full text]  
  • Berckmans, P., Dawans, V., Schmets, G., Vandenbergh, D., Autier, P. (1997). Inappropriate Drug-Donation Practices in Bosnia and Herzegovina, 1992 to 1996. NEJM 337: 1842-1845 [Full text]  
  • Menkes, D. B (1997). Hazardous drugs in developing countries. BMJ 315: 1557-1558 [Full text]  
  • Gregori, A. (1997). Donations of orthopaedic equipment also cause problems. BMJ 314: 1906-1906 [Full text]  

What's new
Student BMJ poll

Resources
Tools
Online poll
Find out more
See previous polls
Services

Rapid responses for this article

There are no rapid responses for this article.
Print issues


Student BMJ

Intimate examinations

Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.

www.student.bmj.com

Listen to the latest BMJ Interview